{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T18:00:08Z","timestamp":1783360808620,"version":"3.54.6"},"reference-count":118,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Quebec Network on Suicide, Mood Disorders and Related Disorders"},{"name":"Canadian Depression Research & Intervention Network (CDRIN)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Child Psychology Psychiatry"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of depressive and mixed symptoms in children and adolescents with bipolar disorder (BD) remains a matter of debate. The goal of this review is, thus, to systematically examine the impact of atypical antipsychotics (AAPs) and mood stabilisers in the treatment of bipolar depression and\/or mixed states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted for studies assessing the efficacy of pharmacological treatments for bipolar disorder type I, type II and not otherwise specified with a recent depressive, mixed or manic episode (with depressive symptoms) following DSM\u2010IV criteria in children and adolescents as either acute or maintenance treatment. The databases searched were PubMed\/Medline, Google Scholar and Tripdatabase, as well as ClinicalTrials.gov. The search was limited to clinical trials, systematic reviews, meta\u2010analyses and open\u2010label trials published in the English language between the years 2000 and 2015. Sixty clinical studies were found assessing the efficacy of mood stabilisers and AAPs in paediatric BD. Fifteen studies were not included in the primary analysis because they did not assess depressive symptomology\/include scores on rating scales of depressive symptoms (Online Supplementary Material).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There is sufficient evidence for a Grade A recommendation of the use of olanzapine plus fluoxetine at reducing depressive symptoms in bipolar depression and of quetiapine at high doses for depressive symptoms occurring during mixed episodes. Importantly, even though monotherapy with aripiprazole, risperidone, valproate and lithium was effective at controlling mania, these drugs were not effective at reducing depressive symptoms (level A evidence for nonrecommendation).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results mostly overlap with the approved treatments for bipolar depression in adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jcpp.12735","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T08:08:48Z","timestamp":1493971728000},"page":"865-879","source":"Crossref","is-referenced-by-count":14,"title":["Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder"],"prefix":"10.1111","volume":"58","author":[{"given":"Tobias","family":"Atkin","sequence":"first","affiliation":[{"name":"Neurobiological Psychiatry Unit Department of Psychiatry McGill University McGill University Health Center Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Neurobiological Psychiatry Unit Department of Psychiatry McGill University McGill University Health Center Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[{"name":"Neurobiological Psychiatry Unit Department of Psychiatry McGill University McGill University Health Center Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.10.1139"},{"key":"e_1_2_7_4_1","unstructured":"Axelson D. Brent D. &Solomon D.(2016).Pediatric bipolar major depression: Choosing treatment.UpToDate. Available from:http:\/\/www.uptodate.com\/contents\/pediatric-bipolar-major-depression-choosing-treatment[last accessed 11 April 2017]."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00965147"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.10.033"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.2008.01953.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.06.010"},{"key":"e_1_2_7_9_1","volume-title":"Psychotropic drug directory 2003\/04","author":"Bazire S.","year":"2003"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2009.00121.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.03.019"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00450.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900021519"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2005.15.311"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(11)70003-9"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048228"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.15.1683"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00146-7"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15l09921"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0812"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.02.018"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000194566.86160.a3"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.18"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3646"},{"key":"e_1_2_7_25_1","unstructured":"Clinicaltrials.gov [Internet]. Bethesda MD: National Library of Medicine(2014).Identifier NCT00181896 Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder. Retrieved fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT00181896"},{"key":"e_1_2_7_26_1","unstructured":"Clinicaltrials.gov [Internet]. Bethesda MD: National Library of Medicine(2014).Identifier NCT02046369 Lurasidone Pediatric Bipolar Study (Illuminate). Retrieved fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02046369."},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31824929d6"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0022-8"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1758-09.2009"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2004.tb00030.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0520"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00728.x"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000159151.75345.20"},{"key":"e_1_2_7_34_1","unstructured":"DelBello M. Findling R. &Wang P.(2008).Efficacy and safety of ziprasidone in pediatric bipolar disorder.Presented at the 161st Annual Meeting of the American Psychiatric Association (APA)."},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000194567.63289.97"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200210000-00011"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2014.12.012"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-9-4"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0029"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12042"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0063"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CHI.0000046893.27264.53"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000189135.05060.8a"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0102"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000155981.83865.ea"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05164yel"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2013.0105"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0743"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07104"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.1508"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.163"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000237945.35022.45"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0317-3"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116636545"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2013.770551"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00750.x"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.3.332"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199503000-00003"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004851.pub3"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454601750143500"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.09.042"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.0162"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200112000-00016"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CHI.0000070247.24125.24"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000129223.89433.74"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.12.009"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/10401230600801176"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200503000-00006"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-7358(98)00010-5"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.8.773"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000242240.69678.c4"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-4993(18)30142-1"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_7_74_1","volume-title":"Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care","author":"National Collaborating Centre for Mental Health","year":"2006"},{"key":"e_1_2_7_75_1","volume-title":"The Oxford 2009 levels of evidence","author":"OCEBM Levels of Evidence Working Group","year":"2009"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13020185"},{"key":"e_1_2_7_77_1","volume-title":"Goodman and Gilman's manual of pharmacology and therapeutics","author":"Parker K.","year":"2008"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07424"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2005.00204.x"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.05.017"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.336"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2010.00850.x"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.0107"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245615"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.4081\/mi.2012.e7"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111704"},{"key":"e_1_2_7_87_1","unstructured":"Powers P. Sachs G. Kushner S. Wang D. Olson W. Capece J. \u2026 &Rosenthal N.(2004).Topiramate in adults with acute bipolar I mania: Pooled results. Paper presented at the 157th Annual Meeting of the American Psychiatric Association New York."},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.64.4.442"},{"key":"e_1_2_7_89_1","volume-title":"Children's depression rating scale, revised (CDRS\u2010R)","author":"Poznanski E.O.","year":"1996"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.040"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00911-5"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200003000-00010"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-6171.2007.00112.x"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.07.004"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.02.012"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i65"},{"key":"e_1_2_7_97_1","volume-title":"Stahl's essential psychopharmacology: Neuroscientific basis and practical applications","author":"Stahl S.M.","year":"2013"},{"key":"e_1_2_7_98_1","volume-title":"The Maudsley prescribing guidelines in psychiatry","author":"Taylor D.","year":"2015"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111932"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04726"},{"key":"e_1_2_7_101_1","unstructured":"US FDA Aripiprazole Prescribing Information.United States Food and Drug Administration. Available from:https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac[last accessed 11 April 2017]."},{"key":"e_1_2_7_102_1","unstructured":"US FDA Carbamazepine Prescribing Information.United States Food and Drug Administration. Available from:http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=e91f9de3-3fdd-0a6b-71ce-53a2cc142816[last accessed 11 April 2017]."},{"key":"e_1_2_7_103_1","unstructured":"US FDA Olanzapine Prescribing Information.United States Food and Drug Administration. Available from:http:\/\/pi.lilly.com\/us\/zyprexa-pi.pdf[last accessed 11 April 2017]."},{"key":"e_1_2_7_104_1","unstructured":"US FDA Oxcarbazepine Prescribing Information.United States Food and Drug Administration. Available from:https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=1c713b59-a628-42e6-b166-ae71c3913284&type=pdf&name=1c713b59-a628-42e6-b166-ae71c3913284[last accessed 11 April 2017]."},{"key":"e_1_2_7_105_1","unstructured":"US FDA Quetiapine Prescribing Information.United States Food and Drug Administration. Available from:https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=b007bac6-a207-481c-8aba-03ade1dd6a88&type=pdf&name=b007bac6-a207-481c-8aba-03ade1dd6a88[last accessed 11 April 2017]."},{"key":"e_1_2_7_106_1","unstructured":"US FDA Risperidone Prescribing Information.United States Food and Drug Administration. Available from:http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=7e117c7e-02fc-4343-92a1-230061dfc5e0[last accessed 11 April 2017]."},{"key":"e_1_2_7_107_1","unstructured":"US FDA Topiramate Prescribing Information.United States Food and Drug Administration. Available from:https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b&type=pdf&name=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b[last accessed 11 April 2017]."},{"key":"e_1_2_7_108_1","unstructured":"US FDA Valproate Prescribing Information. (2012).United States Food and Drug Administration. Available from:http:\/\/www.rxabbvie.com\/pdf\/depakote.pdf[last accessed 11 April 2017]."},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06290"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010611-134540"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16040467"},{"key":"e_1_2_7_112_1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double\u2010blind, randomized, placebo\u2010controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner K.D.","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"e_1_2_7_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e31819c55ec"},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200210000-00012"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0140"},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800320058007"},{"key":"e_1_2_7_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199507000-00010"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0042"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0037"}],"container-title":["Journal of Child Psychology and Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpp.12735","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acamh.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpp.12735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:40:34Z","timestamp":1762191634000},"score":1,"resource":{"primary":{"URL":"https:\/\/acamh.onlinelibrary.wiley.com\/doi\/10.1111\/jcpp.12735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/jcpp.12735"],"URL":"https:\/\/doi.org\/10.1111\/jcpp.12735","archive":["Portico"],"relation":{},"ISSN":["0021-9630","1469-7610"],"issn-type":[{"value":"0021-9630","type":"print"},{"value":"1469-7610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}